-
Rsna2019 NVIDIA Clara federal learning not only brings AI to hospitals, but also protects patient data
Time of Update: 2019-12-02
At the annual conference of the Radiological Society of North America (RSNA), more than 100 exhibitors adopted NVIDIA technology to introduce AI into radiology 2019 seems to be the turning point of AI
-
9 million Magpies! More than 20 billion oral anti-sugar drug market blasted
Time of Update: 2019-11-30
Pharmaceutical Network November 30, November 29, Yabao Pharmaceuticals issued a notice that the company received the State Drug Administration approved the issuance of benzoic acid agretin tablets "d
-
Hebei: Innovative drug enters Phase III clinical trial to give 5 million yuan reward
Time of Update: 2019-11-29
Medicine Network November 29 Reporters learned from the Hebei provincial government, in order to comprehensively improve the scale and quality of the development of the biopharmaceutical industry in
-
The evaluation of the consistency of generic drugs has entered normal and 123 varieties have been reviewed
Time of Update: 2019-11-28
Medicine Network November 28 - Chen Shifei, deputy director of China's State Drug Administration, said in Beijing on the 27th that the evaluation of the consistency of generic drugs has entered the n
-
China's independent research and development of chronic myeloid leukemia treatment drug approved for market
Time of Update: 2019-11-27
Medicine Network November 27th, China's State Drug Administration announced on the 26th, metasulfonate flumartinibinib (commodity name: Hausson Fu) listing registration application was recently appro
-
Can't diagnose neurodevelopmental disorders? AI to help
Time of Update: 2019-11-23
Recently, Mohamed Uddin and Marc Woodbury Smith from the center of applied genomics of children's Hospital in Toronto, Canada, and Yujiang Wang from the Institute of neuroscience, University of Newcas
-
The first two domestically produced generic drugs are about to go on the market!
Time of Update: 2019-11-22
Pharmaceutical network November 22nd, the world's heavyweight varieties of Bevala zhu mono-resistance, domestic first imitation will soon be listed; On November 21, inight database showed that Jian
-
Studies have found that: intestinal microbial disorders lead to intestinal cancer
Time of Update: 2019-11-22
MEDICINE, Nov 22 (Xinhua) -- A recent study from the Department of Microbiology at the University of Coll?ge in France has shown that imbalances in the gut flora can promote the onset of colorectal c
-
AHP treatment drugs were approved in advance for the first time, and the second RNAi treatment was launched
Time of Update: 2019-11-22
Photo source: today, the U.S Food and Drug Administration (FDA) approved givlaari for the treatment of adult acute Porphyra (AHP), the second RNAi drug approved by the FDA after last year's onpattro (
-
Domestic "Peier" will be launched soon
Time of Update: 2019-11-22
Pharmaceutical Network November 22, a few days ago, Watson Biohuman Resources Director, President's Office Director Sun Qing said in public, its heavy products 13 price pneumonia vaccine will soon be
-
Dalian mode: buy medicine nearby with electronic prescription
Time of Update: 2019-11-19
With the electronic prescription issued by doctors, patients can go to the nearest pharmacy to purchase drugs, even through mobile diagnosis and treatment, Internet hospital, etc., and gradually enjoy
-
1.8 billion varieties of the second over-reviewed North China pharmaceutical research and development investment of more than 20 million
Time of Update: 2019-11-19
Pharmaceutical Network November 19, North China Pharmaceuticals issued a notice that the company received the Approval of the State Drug Administration to issue cyclosporine softgel (25mg, 50mg) of t
-
First approval of the listing of autoimmune disease treatment will have domestic medicine
Time of Update: 2019-11-18
Pharmaceutical Network November 18, reporters from the State Drug Administration was informed that Adamu mono-anti-injection (commodity name: Greeli) listing registration application was recently app
-
China's new anti-cancer drug approved for listing in the U.S. Is home-grown research and development
Time of Update: 2019-11-16
Pharmaceutical Network November 16, the U.S Food and Drug Administration (FDA) announced that innovative pharmaceutical company Baiji Shenzhou independently developed the new anti-cancer drug "Zebuti
-
FDA official announcement: approval opinion of zebutini in Baiji China! (full text translation attached)
Time of Update: 2019-11-15
FDA approved the treatment of relapsed refractory mantle cell lymphoma, the clinical trial results show that the effective rate of tumor reduction is very high For Immediate Release: November 14, 2019
-
Scientists are expected to use anthrax toxin to treat bladder cancer!
Time of Update: 2019-11-15
15 (XINHUA) -- Scientists from Purdue University have found that anthrax may help fight bladder cancer, according to the CDC, which kills about 16,000 new people each year in the United States, and b
-
Shocked! Many warning letters of FDA are on the Internet, such as mylan, Xerox
Time of Update: 2019-11-14
Today, the FDA has sent out a series of warning letters, involving Indian pharmaceutical companies cadilla healthcare, swabplus and mylan These companies are suspected of cGMP violations to varying de
-
Domestic lupus new drug taitasip declared to market
Time of Update: 2019-11-14
Pharmaceutical Network November 14th, November 13th, CDE official website shows that Rongchang Bio independently developed the systemic lupus 1 new drug injection with tatasip declared on the market
-
Baiji Shenzhou PD-1 single anti-acceptance status update, only one step away from the listing
Time of Update: 2019-11-14
Medicine Network November 14th, November 12th, Baiji Shenzhou PD-1 product for Lei Lizhu mono-resistance has ended in the CDE review process, is currently in the drug review center review queue This
-
When record breaking becomes the norm, the report card of medical and health consumption trend of e-commerce in the double 11
Time of Update: 2019-11-13
On November 11, the 11th tmall double 11 global carnival was finally settled at 268.4 billion yuan, setting a new record In the opening 145 seconds, the turnover exceeded 100 million yuan; in 10 hours
